Analytical Chemistry in the Regulatory Science of Medical Devices

被引:7
|
作者
Wang, Yi [1 ]
Guan, Allan [1 ]
Wickramasekara, Samanthi [1 ]
Phillips, K. Scott [1 ]
机构
[1] US FDA, Div Biol Chem & Mat Sci, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth,Off Med Prod & Tobacco, Silver Spring, MD 20993 USA
来源
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 11 | 2018年 / 11卷
关键词
medical device; regulatory science; total product life cycle; analytical chemistry; biomaterials; FDA; CIRCULATING TUMOR-CELLS; STAPHYLOCOCCUS-AUREUS; BACTERIAL BIOFILMS; IN-SITU; DIFFERENTIAL ADHESION; RESISTANCE; HEPARIN; CONTAMINATION; CRIZOTINIB; ENRICHMENT;
D O I
10.1146/annurev-anchem-061417-125556
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In the United States, regulatory science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all Food and Drug Administration-regulated products. Good regulatory science facilitates consumer access to innovative medical devices that are safe and effective throughout the Total Product Life Cycle (TPLC). Because the need to measure things is fundamental to the regulatory science of medical devices, analytical chemistry plays an important role, contributing to medical device technology in two ways: It can be an integral part of an innovative medical device (e.g., diagnostic devices), and it can be used to support medical device development throughout the TPLC. In this review, we focus on analytical chemistry as a tool for the regulatory science of medical devices. We highlight recent progress in companion diagnostics, medical devices on chips for preclinical testing, mass spectrometry for postmarket monitoring, and detection/characterization of bacterial biofilm to prevent infections.
引用
收藏
页码:307 / 327
页数:21
相关论文
共 50 条
  • [31] Global Regulatory Challenges for Medical Devices: Impact on Innovation and Market Access
    Amaral, Carolina
    Paiva, Maria
    Rodrigues, Ana Rita
    Veiga, Francisco
    Bell, Victoria
    APPLIED SCIENCES-BASEL, 2024, 14 (20):
  • [32] Regulatory science promotes the translation of transcatheter tricuspid valve repair/replacement devices
    Cheng, Maobo
    Xu, Yun
    Liu, Wei
    Mu, Lanlan
    Lian, Xiaoqi
    Gao, Guobiao
    Sun, Lei
    REGENERATIVE BIOMATERIALS, 2024, 11
  • [33] Analytical Chemistry of Impurities in Amino Acids Used as Nutrients: Recommendations for Regulatory Risk Management
    Karakawa, Sachise
    Smriga, Miro
    Arashida, Naoko
    Nakayama, Akira
    Miyano, Hiroshi
    NUTRIENTS, 2022, 14 (14)
  • [34] Smart polymers advance analytical chemistry
    Zhang, Yahui
    Zhao, Xinjia
    Qing, Guangyan
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2025, 187
  • [35] Regulatory convergence of medical devices: a case study using ISO and IEC standards
    Imagawa, Kuniki
    Mizukami, Yoshiaki
    Miyazaki, Seiko
    EXPERT REVIEW OF MEDICAL DEVICES, 2018, 15 (07) : 497 - 504
  • [36] Integrated Analytical Framework for the Development of Artificial Intelligence-Based Medical Devices
    Arima, Hirokazu
    Kano, Shingo
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (04) : 853 - 865
  • [37] afety Assessment and Global Regulatory Requirements for Genetic Toxicity Evaluations of Medical Devices
    Przygoda, Robert T.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2017, 58 (05) : 375 - 379
  • [38] The analytical evaluation threshold for inorganic metal extractables and leachables analysis of medical devices
    Satori, Chad P.
    Christensen, Catherine D.
    Street, Stephanie M.
    Giffin, Mikaelle
    Pohl, Christopher M.
    Christian, Whitney, V
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2024, 154
  • [39] Regulatory Considerations in the Design and Manufacturing of Implantable 3D-Printed Medical Devices
    Morrison, Robert J.
    Kashlan, Khaled N.
    Flanangan, Colleen L.
    Wright, Jeanne K.
    Green, Glenn E.
    Hollister, Scott J.
    Weatherwax, Kevin J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2015, 8 (05): : 594 - 600
  • [40] Navigating the Regulatory Pathway for Medical Devices—a Conversation with the FDA, Clinicians, Researchers, and Industry Experts
    Aaron E. Lottes
    Kenneth J. Cavanaugh
    Yvonne Yu-Feng Chan
    Vincent J. Devlin
    Craig J. Goergen
    Ronald Jean
    Jacqueline C. Linnes
    Misti Malone
    Raquel Peat
    David G. Reuter
    Kay Taylor
    George R. Wodicka
    Journal of Cardiovascular Translational Research, 2022, 15 : 927 - 943